Thanapon Roddaje, Sinitta Saowarat, Phawit Norchai
Journal: Journal of medicine and life 2026;19(6):433-444
PMID: 42602406
This study aimed to compare the efficacy and short-term tolerability of microneedling combined with either tranexamic acid or vitamin C for melasma. A systematic review and meta-analysis following PRISMA 2020 guidelines was conducted across five databases (MEDLINE, Google Scholar, EBSCO, ProQuest, Web of Science) and ClinicalTrials.gov (2015-2025). Eight studies (232 patients) were synthesized using a random-effects model; outcomes were harmonized across MASI, mMASI, and hemi-MASI using Hedges' g calculated from within-group change-from-baseline scores, with an imputed within-person correlation (r = 0.5; sensitivity range 0.25-0.75) for split-face designs. The pooled analysis showed no statistically significant difference between tranexamic acid and vitamin C (Hedges' g = -0.123; 95% CI, -0.311 to 0.065; P = 0.201; I2 = 0.0%). Exploratory subgroup analyses by microneedling depth, study design, and follow-up duration did not detect a significant interaction but were underpowered and should not be interpreted as confirmatory. Within the short follow-up windows reported (6-16 weeks), both interventions appeared well tolerated, with only mild and transient adverse events; long-term safety, recurrence, and delayed pigmentary complications cannot be characterized from this evidence base. A non-significant pooled difference does not establish therapeutic equivalence in the absence of a pre-specified non-inferiority margin. Microneedling with TXA and microneedling with vitamin C showed comparable short-term outcomes within this limited evidence base. Available data are compatible with a needle depth of ≤1.5 mm being adequate for transdermal delivery. Findings should be interpreted with caution given the modest sample size, predominance of split-face designs, moderate risk of bias in non-randomized studies, and limited power to detect publication bias.
© 2025 The Author(s).
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.